S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1
2018 · Journal of Ovarian Research · 65 citations
https://doi.org/10.1186/s13048-018-0412-1
L
Lucheng Zhu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
86
Papers
967
Citations
18
h-index
30
i10-index
Lucheng Zhu is an academic researcher from Zhejiang Chinese Medical University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 18, co-authored 74 publications.
ORCID: 0000-0001-7298-4166Papers by this author
worksGlasgow prognostic score predicts prognosis of non-small cell lung cancer: a meta-analysis
2016 · SpringerPlus · 37 citations
https://doi.org/10.1186/s40064-016-2093-9
Epidermal growth factor receptor ( <i>EGFR</i> ) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non‐small cell lung cancer progression during first‐generation tyrosine kinase inhibitor therapy: a prospective observational study
2018 · Cancer Communications · 36 citations
https://doi.org/10.1186/s40880-018-0303-2
Deep learning-based automatic delineation of the hippocampus by MRI: geometric and dosimetric evaluation
2021 · Radiation Oncology · 21 citations
https://doi.org/10.1186/s13014-020-01724-y
Comprehensive analysis to identify IL7R as a immunotherapy biomarker from pan-cancer analysis to in vitro validation
2024 · Discover Oncology · 6 citations
https://doi.org/10.1007/s12672-024-01357-7
T790M mutation sensitizes non-small cell lung cancer cells to radiation via suppressing SPOCK1
2024 · Biochemistry and Biophysics Reports · 4 citations
https://doi.org/10.1016/j.bbrep.2024.101729
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat